Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1604 studies found for:    Open Studies | "Genital Diseases, Male"
Show Display Options
Rank Status Study
21 Not yet recruiting Early Screening for Chlamydia Trachomatis in Young Women for Primary Prevention of Pelvic Inflammatory Disease
Condition: Genital Chlamydia Trachomatis Infection
Interventions: Other: Testing for Ct infection immediately;   Other: Testing for Ct infection at the end of the study
22 Not yet recruiting Neoadjuvant And Adjuvant Abiraterone Acetate + Aptilutamide Prostate Cancer Undergoing Prostatectomy
Condition: Prostate Cancer
Interventions: Drug: Aptilutamide;   Drug: Leuprolide;   Drug: Prednisone;   Drug: Abiraterone Acetate;   Procedure: Radical Prostatectomy;   Other: Observation-Post RP
23 Not yet recruiting Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)
Condition: Prostate Cancer
Interventions: Drug: Abiraterone acetate;   Drug: Prednisone;   Drug: Radium-223 dichloride;   Drug: cabazitaxel;   Drug: Carboplatin;   Drug: Enzalutamide
24 Recruiting Fundación IVO Registry for Patients Undergoing Sling or Artificial Urinary Sphincter After Prostate Cancer Treatment
Condition: Urinary Incontinence, Stress
Interventions: Procedure: AMS-800;   Procedure: ADVANCE/ADVANCEXP;   Procedure: VIRTUE;   Procedure: INVANCE
25 Not yet recruiting MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Conditions: Neoplasms;   Lung Neoplasms;   Colon Neoplasms;   Breast Neoplasms;   Pancreatic Neoplasms;   Prostate Neoplasms;   Kidney Neoplasms;   Liver Neoplasms;   Rectal Neoplasms;   Hematologic Neoplasms;   Multiple Myeloma;   Myelodysplastic Syndromes;   Ovarian Neoplasms;   Bladder Neoplasms;   Testicular Neoplasms;   Endometrial Neoplasms;   Brain Neoplasms;   Biliary Tract Neoplasms;   Head and Neck Neoplasms;   Uterine Cervical Neoplasms;   Skin Neoplasms;   Melanoma;   Gastric Neoplasms;   Anal Neoplasms;   Sarcoma
Intervention: Other: Provider determined
26 Recruiting Effect of Letrozole on Seminal Parameters in Men With Non Obstructive Azoospermia and Severe Oligozoospermia.
Conditions: Azoospermia, Nonobstructive;   Oligozoospermia
Intervention: Drug: Letrozole
27 Recruiting Impact of a Sexology Consultation on Disease Control of Type 2 Male Diabetics With Erectile Dysfunction
Conditions: Erectile Dysfunction;   Type 2 Diabetes
Intervention: Procedure: Sexology consultation
28 Not yet recruiting PSMA PET/CT for Prostate Cancer
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Drug: PSMA PET/CT scan
29 Not yet recruiting Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation
Condition: Recurrent Prostate Carcinoma
Interventions: Radiation: High-Dose Rate Brachytherapy;   Procedure: Hyperthermia Treatment
30 Not yet recruiting Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer )
Condition: Prostatic Neoplasms, Castration-Resistant
Intervention: Drug: Xofigo (Radium-223 dichloride, BAY88-8223
31 Recruiting Trans-MAPP II Study of Urologic Chronic Pelvin Pain
Conditions: Interstitial Cystitis;   Chronic Prostatitis
Intervention:
32 Recruiting Engineering an Online STI Prevention Program
Conditions: Sexual Behavior;   Alcohol Consumption;   Sexually Transmitted Diseases
Interventions: Behavioral: Knowledge alone;   Behavioral: Self-efficacy alone;   Behavioral: Perceived benefits alone;   Behavioral: Perceived benefits and self-efficacy;   Behavioral: Injunctive norms;   Behavioral: Injunctive norms and self-efficacy;   Behavioral: Injunctive norms and perceived benefits;   Behavioral: Injunctive norms, perceived benefits, and self-efficacy;   Behavioral: Descriptive norms alone;   Behavioral: Descriptive norms and self-efficacy;   Behavioral: Descriptive norms and perceived benefits;   Behavioral: Descriptive norms,perceived benefits,self-efficacy;   Behavioral: Descriptive and injunctive norms;   Behavioral: Descriptive norms, injunctive norms,self-efficacy;   Behavioral: Descriptive and injunctive norms, benefits;   Behavioral: Descriptive and injunctive norms, benefits,efficacy;   Behavioral: Expectancies alone;   Behavioral: Expectancies and self-efficacy;   Behavioral: Expectancies and Perceived Benefits;   Behavioral: Expectancies, perceived benefits, self-efficacy;   Behavioral: Expectancies and injunctive norms;   Behavioral: Expectancies, injunctive norms, and self-efficacy;   Behavioral: Expectancies, injunctive norms, benefits;   Behavioral: Expectancies, injunctive norms, benefits, efficacy;   Behavioral: Expectancies and descriptive norms;   Behavioral: Expectancies, descriptive norms, and self-efficacy;   Behavioral: Expectancies, descriptive norms, and benefits;   Behavioral: Expectancies,descriptive norms, benefits, efficacy;   Behavioral: Expectancies, descriptive and injunctive norms;   Behavioral: Expectancies, descr& injun norms, efficacy;   Behavioral: Expectancies, desc & injun norms, benefits;   Behavioral: Expectancies,desc & injun norms,benefits,efficacy
33 Not yet recruiting HOUSTON - Incidence of Oropharyngeal, Anal and Penile Cancer in Men With Antibodies to Human Papillomavirus (HPV)
Conditions: Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Lip Oral Cavity and Pharynx;   Malignant Neoplasms of Male Genital Organs
Interventions: Procedure: Oropharyngeal Cancer Screening;   Procedure: Ultrasound Scans;   Procedure: Anal Cancer Screening;   Procedure: High-Resolution Anoscopy (HRA);   Procedure: Penile Cancer Screening
34 Not yet recruiting Predictors of Ovarian Reserve in Infertile Women
Condition: Ovarian Reserve
Intervention: Drug: human menopausal gonadotropin
35 Recruiting Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study
Conditions: Prostate Cancer;   Androgen-deprivation Therapy
Intervention: Other: Standard care
36 Not yet recruiting Olaparib With or Without Cediranib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation;   Prostate Carcinoma Metastatic in the Bone;   Prostate Small Cell Carcinoma;   Stage IV Prostate Adenocarcinoma
Interventions: Drug: Cediranib;   Other: Laboratory Biomarker Analysis;   Drug: Olaparib
37 Not yet recruiting NATural Ovarian Stimulation
Condition: Infertility
Interventions: Drug: Gonal-F®;   Drug: Cetrotide®
38 Not yet recruiting Sildenafil Effect After Ovulation Induction
Condition: Infertility
Interventions: Drug: Clomiphene citrate;   Drug: sildenafil citrate;   Drug: Placebo
39 Recruiting The Platinum Study Comparison Group
Condition: Testicular Neoplasms
Intervention: Behavioral: Questionnaire
40 Not yet recruiting A Retrospective Study in Chinese Good Prognosis Patients Undergoing Assisted Reproductive Technology (ART) Treatment
Condition: Infertility
Intervention: Drug: No Intervention

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years